OPTN Vascularized Composite Allograft Waiting List: Current Status and Trends in the United States

Transplantation
J L WainrightD K Klassen

Abstract

Vascularized composite allograft (VCA) transplantation is a developing area in the field of transplantation. This study used Organ Procurement and Transplantation Network (OPTN) VCA waiting list and transplant data from July 3, 2014 through February 28, 2018, to characterize the OPTN VCA waiting list in terms of composition, removal patterns, waiting time, resulting transplants, and trends over time. Between implementation of the OPTN VCA waiting list on July 3, 2014 and February 28, 2018, 54 candidates-53.7% were male, 79.6% were white, and 70.4% aged 18 to 44 years-were added to the OPTN VCA waiting list. Of these, 22 received deceased donor VCA transplants (6 bilateral upper limb, 4 unilateral upper limb, 5 craniofacial, 1 scalp, 1 abdominal wall, 1 penile, and 4 uterine), and 6 received living donor uterine transplants. Registrations increased in 2016 after uterine and penile transplants were introduced in the United States, resulting in a large shift in the composition of the VCA waiting list. Waiting times for VCA candidates vary greatly, with some VCA candidates receiving deceased donor transplants quickly and others waiting more than 3 years before transplantation. The field of VCA transplantation and the composition of...Continue Reading

References

Feb 26, 2008·Archives of Physical Medicine and Rehabilitation·Kathryn Ziegler-GrahamRon Brookmeyer
Jan 5, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·L CendalesUNKNOWN ASTS VCA Ad Hoc Committee and Executive Committee
Mar 28, 2012·Transplant International : Official Journal of the European Society for Organ Transplantation·Martin KumnigStefan Schneeberger
Jul 23, 2013·Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS·Blake D MurphyGregory H Borschel
Nov 19, 2013·Current Reviews in Musculoskeletal Medicine·River M ElliottL Scott Levin
Aug 19, 2015·Transplant International : Official Journal of the European Society for Organ Transplantation·Alexandra K Glazier
Feb 27, 2016·International Journal of Women's Health·Liza Johannesson, Stina Järvholm
Jul 9, 2016·Transplantation·Arthur L CaplanEduardo D Rodriguez

❮ Previous
Next ❯

Citations

Sep 21, 2018·Transplantation·Jennifer L WainrightDavid K Klassen
Oct 3, 2019·Current Opinion in Organ Transplantation·Macey L Henderson
Jun 3, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Holly C Lewis, Linda C Cendales
Sep 25, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Gabriel R VeceJennifer Wainright
May 27, 2021·Plastic and Reconstructive Surgery. Global Open·Gustave K DiepEduardo D Rodriguez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Clinical Journal of the American Society of Nephrology : CJASN
J L WainrightD E Stewart
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
M R JohnsonD B Dyke
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Jagbir GillMichael Cecka
© 2022 Meta ULC. All rights reserved